A rival bid from a suitor who hopes to get maybe 40% of the company?They're sure won't get the 50+% that Wyloo has, so why would they bother?Seems extremely unlikely.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution